[
    [
        {
            "time": "2023-10-10",
            "original_text": "医药生物板块逆势大涨，这一细分领域翻倍股扎堆",
            "features": {
                "keywords": [
                    "医药生物",
                    "逆势",
                    "大涨",
                    "翻倍股"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物板块逆势大涨，这一细分领域翻倍股扎堆",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "速读社丨AZ/FibroGen肾性贫血药物因安全性再遭FDA质疑 梯瓦MS重磅药在中国申报上市",
            "features": {
                "keywords": [
                    "AZ",
                    "FibroGen",
                    "肾性贫血",
                    "FDA",
                    "梯瓦",
                    "MS重磅药"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "速读社丨AZ/FibroGen肾性贫血药物因安全性再遭FDA质疑 梯瓦MS重磅药在中国申报上市",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "北向资金 | 合计净流出108.06亿元，宁德时代、比亚迪、恩捷股份、药明康德净卖出居前",
            "features": {
                "keywords": [
                    "北向资金",
                    "净流出",
                    "宁德时代",
                    "比亚迪",
                    "药明康德"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "新能源",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "北向资金 | 合计净流出108.06亿元，宁德时代、比亚迪、恩捷股份、药明康德净卖出居前",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-07-14",
            "original_text": "A股资金流向（7月14日）：新能源产业链集体退潮",
            "features": {
                "keywords": [
                    "A股",
                    "资金流向",
                    "新能源",
                    "退潮"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "新能源"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "A股资金流向（7月14日）：新能源产业链集体退潮",
                "Correlation": 7,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "医药生物行业周报：医药板块估值已具备吸引力 建议长期配置优质赛道",
            "features": {
                "keywords": [
                    "医药生物",
                    "估值",
                    "吸引力",
                    "长期配置"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药生物行业周报：医药板块估值已具备吸引力 建议长期配置优质赛道",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "医药生物行业周报：短期受政策扰动 关注中报高成长个股",
            "features": {
                "keywords": [
                    "医药生物",
                    "政策扰动",
                    "中报",
                    "高成长"
                ],
                "sentiment_score": -0.5,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药生物行业周报：短期受政策扰动 关注中报高成长个股",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "港股医药股持续发力，药明生物大涨逾8%",
            "features": {
                "keywords": [
                    "港股",
                    "医药股",
                    "药明生物",
                    "大涨"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "港股医药股持续发力，药明生物大涨逾8%",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 7,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "CXO板块逆势走强，康龙化成涨超5%再创新高",
            "features": {
                "keywords": [
                    "CXO",
                    "逆势",
                    "走强",
                    "康龙化成"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "CXO板块逆势走强，康龙化成涨超5%再创新高",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "北向资金动向盘点：连续净买入“通信”",
            "features": {
                "keywords": [
                    "北向资金",
                    "动向",
                    "通信",
                    "净买入"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "通信"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "北向资金动向盘点：连续净买入“通信”",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "北向资金抛售医药白酒，大幅卖出比亚迪（附股）",
            "features": {
                "keywords": [
                    "北向资金",
                    "抛售",
                    "医药",
                    "白酒",
                    "比亚迪"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "白酒"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "北向资金抛售医药白酒，大幅卖出比亚迪（附股）",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]